Tag: Stem Cells

Overall survival rates were 29.8 and 21.6 percent five and 10 years after hematopoietic stem cell transplant

Haploidentical stem cell transplantation using nonmyeloablative conditioning regimen effective in highly selected patients

Most significant pain relief see with adipose‐derived and umbilical cord‐derived stem cells at different postoperative months

Diversity and composition of gut microbiota before transplantation associated with survival

Depth of response following autologous stem cell transplant remains a key predictor of survival

All received stem cell transplants to treat cancer; however, sixth patient did not receive the transplant from a donor with a rare genetic abnormality that is resistant to HIV

Higher spleen volume tied to inferior overall survival and increased incidence of nonrelapse mortality for patients with AML undergoing hematopoietic stem cell transplant

GVHD-free, relapse-free survival more common among those receiving cyclophosphamide-tacrolimus-mycophenolate mofetil prophylaxis

Findings among patients with acute myeloid leukemia and second complete remission

The hope is that the model embryos will help researchers understand what happens between fertilization and the first 14 days